• Something wrong with this record ?

Enzymatic synthesis of dimeric glycomimetic ligands of NK cell activation receptors

A. Drozdová, P. Bojarová, K. Křenek, L. Weignerová, B. Henssen, L. Elling, H. Christensen, HH. Jensen, H. Pelantová, M. Kuzma, K. Bezouška, M. Krupová, D. Adámek, K. Slámová, V. Křen,

. 2011 ; 346 (12) : 1599-609. [pub] 20110503

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

This work reveals new structural relationships in the complex process of the interaction between activation receptors of natural killer cells (rat NKR-P1, human CD69) and novel bivalent carbohydrate glycomimetics. The length, glycosylation pattern and linker structure of receptor ligands were examined with respect to their ability to precipitate the receptor protein from solution, which simulates the in vivo process of receptor aggregation during NK cell activation. It was found that di-LacdiNAc triazole compounds show optimal performance, reaching up to 100% precipitation of the present protein receptors, and achieving high immunostimulatory activities without any tendency to trigger activation-induced apoptosis. In the synthesis of the compounds tested, two enzymatic approaches were applied. Whereas a β-N-acetylhexosaminidase could only glycosylate one of the two acceptor sites available with yields below 10%, the Y284L mutant of human placental β1,4-galactosyltransferase-1 worked as a perfect synthetic tool, accomplishing even quantitative glycosylation at both acceptor sites and with absolute regioselectivity for the C-4 position. This work insinuates new directions for further ligand structure optimisation and demonstrates the strong synthetic potential of the mutant human placental β1,4-galactosyltransferase-1 in the synthesis of multivalent glycomimetics and glycomaterials.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12028279
003      
CZ-PrNML
005      
20121206123444.0
007      
ta
008      
120817e20110503ne f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.carres.2011.04.043 $2 doi
035    __
$a (PubMed)21641586
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Drozdová, Anna $u Institute of Microbiology, Academy of Sciences of Czech Republic, Vídeňská 1083, CZ-14220 Praha 4, Czech Republic.
245    10
$a Enzymatic synthesis of dimeric glycomimetic ligands of NK cell activation receptors / $c A. Drozdová, P. Bojarová, K. Křenek, L. Weignerová, B. Henssen, L. Elling, H. Christensen, HH. Jensen, H. Pelantová, M. Kuzma, K. Bezouška, M. Krupová, D. Adámek, K. Slámová, V. Křen,
520    9_
$a This work reveals new structural relationships in the complex process of the interaction between activation receptors of natural killer cells (rat NKR-P1, human CD69) and novel bivalent carbohydrate glycomimetics. The length, glycosylation pattern and linker structure of receptor ligands were examined with respect to their ability to precipitate the receptor protein from solution, which simulates the in vivo process of receptor aggregation during NK cell activation. It was found that di-LacdiNAc triazole compounds show optimal performance, reaching up to 100% precipitation of the present protein receptors, and achieving high immunostimulatory activities without any tendency to trigger activation-induced apoptosis. In the synthesis of the compounds tested, two enzymatic approaches were applied. Whereas a β-N-acetylhexosaminidase could only glycosylate one of the two acceptor sites available with yields below 10%, the Y284L mutant of human placental β1,4-galactosyltransferase-1 worked as a perfect synthetic tool, accomplishing even quantitative glycosylation at both acceptor sites and with absolute regioselectivity for the C-4 position. This work insinuates new directions for further ligand structure optimisation and demonstrates the strong synthetic potential of the mutant human placental β1,4-galactosyltransferase-1 in the synthesis of multivalent glycomimetics and glycomaterials.
650    _2
$a zvířata $7 D000818
650    _2
$a CD antigeny $x imunologie $x metabolismus $7 D015703
650    _2
$a diferenciační antigeny T-lymfocytů $x imunologie $x metabolismus $7 D000945
650    _2
$a vazebná místa $x účinky léků $x imunologie $7 D001665
650    _2
$a biomimetika $x metody $7 D032701
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a galaktosyltransferasy $x genetika $x metabolismus $7 D005700
650    _2
$a lidé $7 D006801
650    _2
$a imunoprecipitace $7 D047468
650    _2
$a buňky NK $x chemie $x účinky léků $x imunologie $x metabolismus $7 D007694
650    _2
$a lektiny typu C $x agonisté $x imunologie $x metabolismus $7 D037181
650    _2
$a ligandy $7 D008024
650    _2
$a aktivace lymfocytů $x účinky léků $x imunologie $7 D008213
650    _2
$a molekulární mimikry $7 D018716
650    _2
$a mutace $7 D009154
650    _2
$a placenta $x enzymologie $7 D010920
650    _2
$a polysacharidy $x chemická syntéza $x farmakologie $7 D011134
650    _2
$a těhotenství $7 D011247
650    _2
$a vazba proteinů $x účinky léků $x imunologie $7 D011485
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a receptory buněk NK $x agonisté $x imunologie $x metabolismus $7 D055607
650    _2
$a rekombinantní proteiny $x genetika $x metabolismus $7 D011994
650    _2
$a beta-N-acetylhexosaminidasy $x metabolismus $7 D001619
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bojarová, Pavla
700    1_
$a Křenek, Karel
700    1_
$a Weignerová, Lenka
700    1_
$a Henssen, Birgit
700    1_
$a Elling, Lothar
700    1_
$a Christensen, Helle
700    1_
$a Jensen, Henrik H
700    1_
$a Pelantová, Helena
700    1_
$a Kuzma, Marek
700    1_
$a Bezouška, Karel
700    1_
$a Krupová, Monika
700    1_
$a Adámek, David $7 gn_A_00001276
700    1_
$a Slámová, Kristýna
700    1_
$a Křen, Vladimír
773    0_
$w MED00001049 $t Carbohydrate research $x 1873-426X $g Roč. 346, č. 12 (20110503), s. 1599-609
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21641586 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121206123518 $b ABA008
999    __
$a ok $b bmc $g 950321 $s 785625
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 346 $c 12 $d 1599-609 $e 20110503 $i 1873-426X $m Carbohydrate research $n Carbohydr Res $x MED00001049
LZP    __
$a Pubmed-20120817/11/04

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...